Moneycontrol
SENSEX NIFTY
you are here:

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA | Series: NA | ISIN: INE406A01037 | SECTOR: Pharmaceuticals

BSE Live

Jul 03, 16:00
778.30 -1.40 (-0.18%)
Volume
AVERAGE VOLUME
5-Day
98,361
10-Day
112,184
30-Day
153,511
43,783
  • Prev. Close

    779.70

  • Open Price

    780.00

  • Bid Price (Qty.)

    777.00 (125)

  • Offer Price (Qty.)

    778.30 (503)

NSE Live

Jul 03, 15:58
777.85 -2.00 (-0.26%)
Volume
AVERAGE VOLUME
5-Day
3,103,050
10-Day
3,520,064
30-Day
4,946,148
1,415,552
  • Prev. Close

    779.85

  • Open Price

    784.05

  • Bid Price (Qty.)

    777.85 (37)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2019 2018 2017 2016 2015
Quarterly Results of Aurobindo Pharma (in Rs. Cr.) Mar '20 Dec '19 Sep '19 Jun '19 Mar '19  
Net Sales/Income from operations 6,063.40 5,799.44 5,518.27 5,356.84 5,201.98  
Other Operating Income 95.03 95.56 82.20 87.76 90.22  
Total Income From Operations 6,158.43 5,895.00 5,600.47 5,444.60 5,292.20  
EXPENDITURE  
Consumption of Raw Materials 2,037.98 2,011.15 1,815.47 1,860.38 1,991.29  
Purchase of Traded Goods 513.24 553.10 515.70 530.07 512.22  
Increase/Decrease in Stocks -47.85 0.75 37.15 -91.91 -130.88  
Power & Fuel -- -- -- -- --  
Employees Cost 864.33 797.80 777.19 779.86 713.46  
Depreciation 232.41 250.13 243.31 240.86 186.62  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 1,474.51 1,324.16 1,314.74 1,219.80 1,148.64  
P/L Before Other Inc., Int., Excpt. Items & Tax 1,083.81 957.91 896.91 905.54 870.85  
Other Income 32.59 30.93 20.62 15.78 32.27  
P/L Before Int., Excpt. Items & Tax 1,116.40 988.84 917.53 921.32 903.12  
Interest 31.83 37.11 40.94 49.89 50.08  
P/L Before Exceptional Items & Tax 1,084.57 951.73 876.59 871.43 853.04  
Exceptional Items 12.25 -12.92 -12.76 -12.70 -36.18  
P/L Before Tax 1,096.82 938.81 863.83 858.73 816.86  
Tax 228.52 232.86 224.37 227.76 231.12  
P/L After Tax from Ordinary Activities 868.30 705.95 639.46 630.97 585.74  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 868.30 705.95 639.46 630.97 585.74  
Minority Interest 0.84 0.14 0.33 -- 0.16  
Share Of P/L Of Associates -19.31 -0.64 0.07 4.71 -0.52  
Net P/L After M.I & Associates 849.83 705.45 639.86 635.68 585.38  
Equity Share Capital 58.59 58.59 58.59 58.59 58.59  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 14.50 12.04 10.92 10.85 9.99  
Diluted EPS 14.50 12.04 10.92 10.85 9.99  
EPS After Extra Ordinary  
Basic EPS. 14.50 12.04 10.92 10.85 9.99  
Diluted EPS. 14.50 12.04 10.92 10.85 9.99  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited